Login / Signup

Capturing the systemic immune signature of a norovirus infection: an n-of-1 case study within a clinical trial.

Antony J CutlerJoao OliveiraRicardo C FerreiraBen ChallisNeil M WalkerSarah CaddyJia LuHelen E StevensDeborah J SmythMarcin L PekalskiJane KennetKara M D HunterIan GoodfellowLinda S WickerJohn A ToddFrank Waldron-Lynch
Published in: Wellcome open research (2017)
The results illustrate the innate, adaptive and counter-regulatory immune responses to norovirus infection. Low-dose IL-2 administration induces many of the Treg responses observed during infection.
Keyphrases
  • immune response
  • low dose
  • clinical trial
  • high dose
  • dendritic cells
  • open label
  • inflammatory response
  • double blind
  • phase ii